Integrated Filing — IndAS



General information about company

Scrip Code 545001
NSE Symbol SMT
MSEI Symbol NOTLISTED
ISIN INE356Y01018
Name of company Sahajanand Medical Technologies Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 05-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Cardiovascular Devices
Start date and time of board meeting 05-11-2026   15:00:00
End date and time of board meeting 05-11-2026   16:43:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 37,341.01 72,507.86
Other income 223.58 490.08
Total income 37,564.59 72,997.94
2 Expenses
(a) Cost of materials consumed 7,995.42 14,303.38
(b) Purchases of stock-in-trade 3,368.22 6,621.79
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (1,802.48) (2,255.17)
(d) Employee benefit expense 10,127.47 19,866.57
(e) Finance costs 681.18 1,335.83
(f) Depreciation, depletion and amortisation expense 2,090.91 4,132.18
(f) Other Expenses
1 Other Expenses 11,097.00 22,557.97
Total other expenses 11,097.00 22,557.97
Total expenses 33,557.72 66,562.55
3 Total profit before exceptional items and tax 4,006.87 6,435.39
4 Exceptional items 0.00 0.00
5 Total profit before tax 4,006.87 6,435.39
6 Tax expense
7 Current tax 1,288.64 2,384.19
8 Deferred tax 71.31 (104.95)
9 Total tax expenses 1,359.95 2,279.24
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,646.92 4,156.15
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,646.92 4,156.15
17 Other comprehensive income net of taxes 171.08 (175.93)
18 Total Comprehensive Income for the period 2,818.00 3,980.22
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 2,579.06 4,036.25
Total profit or loss, attributable to non-controlling interests 67.86 119.90
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 2,745.58 3,860.98
Total comprehensive income for the period attributable to owners of parent non-controlling interests 72.42 119.24
21 Details of equity share capital
Paid-up equity share capital 981.31 981.31
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.63 4.11
Diluted earnings (loss) per share from continuing operations 2.56 4.01
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.63 4.11
Diluted earnings (loss) per share from continuing and discontinued operations 2.56 4.01
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Explanatory Notes to the Unaudited Consolidated Financial Results: 1. The Unaudited Consolidated Financial Results for the quarter and six month ended 30 September, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 05 November, 2026 and a limited review of the same has been carried out by the Statutory Auditors of the Company. 2. The Parent Company's equity shares have been listed on Bombay Stock Exchange Limited (BSE) and on National Stock Exchange of India Limited (NSE) on 23 October 2026 by completing Initial Public Offering of 1,38,22,116 equity shares of face value of Re. 1 each and issue price of Rs. 344 per equity share, consisting of an offer for sale by selling shareholders. Accordingly, the above Statement of Unaudited Consolidated Financial Results for the quarter and six months ended 30 September 2026 (the Statement) are drawn up in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, (Listing Requirements) as amended. 3. The Unaudited Consolidated Financial Results of Sahajanand Medical Technologies Limited� (the Parent/ “Company”) and its Subsidiaries (the parent and its subsidiaries together referred to as the Group) comprises the Consolidated Statement of Profit and Loss (including Other Comprehensive Income) for the quarter and six month ended 30 September, 2026 and Explanatory Notes (together referred to as the “Unaudited Consolidated Financial Results”). The Unaudited Consolidated Financial Results have been prepared in accordance with the recognition and measurement principle of Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”) prescribed under Section 133 of the Companies Act, 2013 (the “Act”), read with relevant rules issued thereunder and other accounting principles generally accepted in India and in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 4. The Group is engaged in the business of manufacturing Balloon Catheter, Cardiac Stents, TAVI and Occluder and the Company's Chief Operating Decision Maker (CODM) evaluates the Company's performance, allocates resources as a single segment Cardiovascular Devices. Accordingly, no separate disclosure of segment has been made. 5. The Unaudited Consolidated Financial Results and notes are also available on the websites of Stock Exchange via www.bseindia.com and www.nseindia.com and also on the website of the Parent Company at www.smtpl.com.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 27,751.30
Capital work-in-progress 1,458.88
Investment property
Goodwill 4,937.07
Other intangible assets 1,144.27
Intangible assets under development 75.98
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 2,998.44
Trade receivables, non-current
Loans, non-current 369.30
Other non-current financial assets
1 Security Deposits 921.63
2 Deposits with banks with maturity of more than 12 months (refer footnote) 427.69
3 Interest Receivable on Unsecured Loans & Deposits 34.46
4 Income Tax Assets (net) 98.84
Total of other non-current financial assets 1,482.62
Total non-current financial assets 4,850.36
Deferred tax assets (net) 5,182.38
Other non-current assets
1 Indirect taxes recoverable 218.18
2 Capital Advance 140.06
3 Prepaid expenses 21.19
4 Balance with Government Authorities (paid under protest) 1,268.21
Total of other non-current assets 1,647.64
Total non-current assets 47,047.88
2 Current assets
Inventories 33,026.96
Current financial asset
Current investments 3,301.28
Trade receivables, current 31,814.80
Cash and cash equivalents 7,816.40
Bank balance other than cash and cash equivalents 316.32
Loans, current 82.77
Other current financial assets
Total of other current financial assets 2,251.89
Total current financial assets 45,583.46
Current tax assets (net)
Other current assets
1 Indirect taxes recoverable (Net of provision: Rs.4,493.13 lacs) 3,816.47
2 Advance to suppliers 1,676.99
3 Prepaid expenses 1,315.52
4 Advances to employees 139.77
Total of other current assets 6,948.75
Total current assets 85,559.17
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,32,607.05
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 981.31
Other equity 72,747.20
Total equity attributable to owners of parent 73,728.51
Non controlling interest 802.47
Total equity 74,530.98
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 6,580.93
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liabilities 1,803.13
2 Security Deposits from others 2.25
3 Security Deposit from Customer 16.23
4 Put option liability towards Non-controlling Interest Shareholder 323.84
5 Employee related liabilities 559.33
6 Gratuity Payable 737.10
Total of other non-current financial liabilities 3,441.88
Total non-current financial liabilities 10,022.81
Provisions, non-current 119.24
Deferred tax liabilities (net) 249.88
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 10,391.93
Current liabilities
Current financial liabilities
Borrowings, current 23,588.98
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 669.90
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 9,624.66
Total Trade payable 10,294.56
Other current financial liabilities
1 Lease Liabilities 1,203.98
2 Capital Creditors 188.36
3 Employee related liabilities 3,371.38
4 Interest accrued but not due on borrowings 298.03
5 Leave Encashment Payable 1,679.33
6 Other Payables 54.49
Total of other current financial liabilities 6,795.57
Total current financial liabilities 40,679.11
Other current liabilities 2,136.40
1 Contract Liabilities (Refer footnote below) 377.49
2 Deferred Income 0.47
3 Statutory dues 1,758.44
Total of other current liabilities 2,136.40
Provisions, current 206.40
Current tax liabilities (Net) 4,662.23
Deferred government grants, Current
Total current liabilities 47,684.14
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 58,076.07
Total equity and liabilites 1,32,607.05
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement Income on defined benefit obligation 0.00 (216.92)
Total Amount of items that will not be reclassified to profit and loss 0.00 (216.92)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 (50.87)
3 Amount of items that will be reclassified to profit and loss
1 Exchange Gain on translation of financial statements of foreign operations 171.08 0.00
2 Exchange loss on translation of financial statements of foreign operations 0.00 (9.88)
Total Amount of items that will be reclassified to profit and loss 171.08 (9.88)
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 171.08 (175.93)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 6,435.39
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,335.83
Adjustments for decrease (increase) in inventories (2,104.24)
Adjustments for decrease (increase) in trade receivables, current (2,481.04)
Adjustments for decrease (increase) in trade receivables, non-current 7.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 927.17
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 4,132.18
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss (197.13)
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (1,442.77)
Adjustments for dividend income 0.00
Adjustments for interest income 169.60
Adjustments for share-based payments 321.29
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (20.38)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 308.31
Net cash flows from (used in) operations 6,743.70
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,007.30
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 4,736.40
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 316.30
Other cash payments to acquire equity or debt instruments of other entities 759.67
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 62.81
Purchase of property, plant and equipment 4,213.28
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 4.23
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 299.93
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 316.90
Net cash flows from (used in) investing activities (3,981.24)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 1,708.12
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 3,399.41
Repayments of borrowings 125.06
Payments of lease liabilities 759.20
Dividends paid 0.00
Interest paid 1,144.24
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (337.21)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 417.95
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents (3.85)
Net increase (decrease) in cash and cash equivalents 414.10
Cash and cash equivalents cash flow statement at beginning of period 7,409.30
Cash and cash equivalents cash flow statement at end of period 7,823.40